Case Report
Accepted on 13 Jun 2025
Case Reports: Subcutaneous ofatumumab for Patients with Immunosuppressant-Dependent or Ineffective Primary Membranous Nephropathy
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
- 150 views